Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol in elderly patients undergoing thoracoscopic surgery with bronchial anesthesia
ChiCTR2400094127Phase 4Completed
- Sponsor
- Chongqing University Affiliated Three Gorges Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in bronchial carcinoma (2 arms), sponsored by Chongqing University Affiliated Three Gorges Hospital. Primary endpoints: Serum TNF-alpha, S100beta, C-reactive protein, and interleukin-6 concentrations and Venous blood routine. Started Jan 2024; status: completed.
02
Drugs
remimazolampropofol
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2400094127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094127.